InsidersTradesSigma
Track the Parallax Health Sciences, INC. share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Technology sector, Parallax Health Sciences, INC. has logged 1 reports. Market capitalisation: €1,096.4bn. The latest transaction was filed on 17 March 2022 (J). Among the most active insiders: WITHROW EDWARD W III. Every trade is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Parallax Health Sciences, INC. Strong Buy (bullish), based on 42 analysts. Average price target: US$1,491.95.
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,794 of 28,717 companies
71.3
score / 100
Value64
Quality79
FCF yld1.2%
Earn yld6.4%
EV/EBITDA8.1x
ROE67%
Gross mgn40%
Net mgn23%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 March 2022
Declarations1 total
7,050,773 shares@ US$0.080.0001% mcap100.0% of flowCOMMON STOCKSEC:0001388410-22-000004:0
1 of 1 declaration
About Parallax Health Sciences, INC.
Parallax Health Sciences, INC. is a technology company focused on developing innovative health solutions. It is listed on the XNAS market.